Evidence map›Paper›PMID 30931129›Full record

ArticleMaterials horizons2019

Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage.

Daniel E Mitchell, Alice E R Fayter, Robert C Deller, Muhammad Hasan, Jose Gutierrez-Marcos, Matthew I Gibson

Open access · hybridAbstract read
In one paragraph

Article in Materials horizons, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Ice Inhibition for Cryopreservation: Materials, Strategies, and Challenges.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daniel E MitchellDepartment of Chemistry , University of Warwick , Coventry , CV47AL , UK . Email: M.i.gibson@warwick.ac.uk.
Alice E R FayterDepartment of Chemistry , University of Warwick , Coventry , CV47AL , UK . Email: M.i.gibson@warwick.ac.uk.ORCID 0000-0001-9470-9560
Robert C DellerDepartment of Chemistry , University of Warwick , Coventry , CV47AL , UK . Email: M.i.gibson@warwick.ac.uk.ORCID 0000-0002-5812-583X
Muhammad HasanDepartment of Chemistry , University of Warwick , Coventry , CV47AL , UK . Email: M.i.gibson@warwick.ac.uk.ORCID 0000-0003-3201-7184
Jose Gutierrez-MarcosSchool of Life Sciences , University of Warwick , Coventry , CV47AL , UK.
Matthew I GibsonDepartment of Chemistry , University of Warwick , Coventry , CV47AL , UK . Email: M.i.gibson@warwick.ac.uk.ORCID 0000-0002-8297-1278
University of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteins are ubiquitous in molecular biotechnology, biotechnology and as therapeutics, but there are significant challenges in their storage and distribution, with freezing often required. This is traditionally achieved by the addition of cryoprotective agents such as glycerol (or trehalose) or covalent modification of mutated proteins with cryoprotectants. Here, ice recrystallization inhibiting polymers, inspired by antifreeze proteins, are used synergistically with poly(ethylene glycol) as an alternative to glycerol. The primary mechanism of action appears to be preventing irreversible aggregation due to ice growth. The polymer formulation is successfully used to cryopreserve a range of important proteins including insulin, Taq DNA polymerase and an IgG antibody. The polymers do not require covalent conjugation, nor modification of the protein and are already used in a wide range of biomedical applications, which will facilitate translation to a range of biologics.

Identifiers

PMID30931129
PMCPMC6394881
OpenAlexW2900131190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.